Exposure to anti-malarial drugs and monitoring of adverse drug reactions using toll-free mobile phone calls in private retail sector in Sagamu, Nigeria: Implications for pharmacovigilance

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Adedeji, Ahmed A ^a,b   Sanusi, Bilqees ^a   Tella, Azeez ^a   Akinsanya, Motunrayo ^a   Ojo, Olubusola ^a   Akinwunmi, Mufliat O ^a   Tikare, Olubukola A ^c   Ogunwande, Isiaka A ^a,d   Ogundahunsi, Omobola A ^a   Ayilara, Olajide O ^a   Ademola, Taofeeqah T ^a   Fehintola, Fatai A ^e   Ogundahunsi, Olumide AT ^f  

^a OLABISI ONABANJO UNIVERSITY   (Nigeria)

^b KAMPALA INTERNATIONAL UNIVERSITY   (Uganda)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d LAGOS STATE UNIVERSITY   (Nigeria)

^e UNIVERSITY OF IBADAN   (Nigeria)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ARTEMETHER; ARTESUNATE; BENFLUMETOL; CHLOROQUINE; HALOFANTRINE; HERBACEOUS AGENT; PROGUANIL; QUININE; SULFADOXINE;

ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG EXPOSURE; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOBILE PHONE; MONOTHERAPY; NIGERIA; TELEMEDICINE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; DRUG UTILIZATION; EVALUATION; STATISTICS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIMALARIALS; CELLULAR PHONE; DRUG UTILIZATION; HUMANS; NIGERIA;

EID: 79961161135     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-230     Document Type: Article

References (18)

1. Federal Ministry of Health, National Antimalarial Treatment Policy Abuja, Nigeria: Federal Ministry of Health 2004
2. World Health Organization, World Malaria Day April 25th 2010 http://www.who.int/malaria/en/
3. Effect of artemisinin-based treatment policy on consumption pattern of antimalarials. Mokuolu OA, Okoro EO, Ayetoro SO, Adewara AA, Am J Trop Med Hyg 2007 76 7 11 17255221 (Pubitemid 351627794)
4. Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia. Lyda O, Iveth G, Piero O, Walt RJ, Malar J 2007 6 25 10.1186/1475-2875-6-25 17328806 (Pubitemid 46437047)
5. Evaluation of adverse drug reactions to artemisinin-based combination therapy in a Nigeria university community. Adisa R, Fakeye TO, Dike D, Trop J Pharm Res 2008 7 937 944
6. Exploring and improving access to health care in contexts of livelihood in security. Towards a framework for analysis and action. Orbit B, Iteba N, Lengler C, Makemba A, Mshana C, Mshinda H, Nathan R, Alba S, Dillip A, Hetzel MW, Mayumana I, Schulze A, PLos Med 2007 4 308 10.1371/journal.pmed.0040308 (Pubitemid 350035449)
7. Self-treatment for malaria: the evidence and methodological issues. McCombie SC, Health Policy Plan 2002 17 333 344 10.1093/heapol/17.4.333 12424205 (Pubitemid 35477377)
8. Retail supply of malaria-related drugs in rural Tanzania: risk and opportunities. Goodman C, Kachur SP, Abdulla S, Mwageni E, Nyoni J, Schellenberg JA, Mills A, Bloland P, Trop Med Int Health 2004 9 655 633 10.1111/j.1365-3156. 2004.01245.x 15189455 (Pubitemid 38833330)
9. Antimalarial drug toxicity: a review. Taylor WR, White NJ, Drug Saf 2004 27 25 61 14720085 (Pubitemid 38186936)
10. Malaria in Nigeria. A revisit. Salako LAS, Ajayi FO, Sowunmi A, Walker O, Ann Trop Med Parasitol 1990 84 435 445 2256767
11. Pharmacovigilance of anti-malarial treatment in Africa: is it possible? Talisuna AO, Staedke SG, D'Alessandro U, Malar J 2006 5 50 10.1186/1475-2875-5- 50 16780575 (Pubitemid 44141482)
12. Open randomized study of pyrimethamine sulphadoxine vs. pyrimethamine-sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children. Sowunmi A, Fehintola FA, Adedeji AA, Gbotosho GO, Falade CO, Tambo E, Fateye BA, Happi TC, Oduola AMJ, Trop Med Int Health 2004 9 606 19 10.1111/j.1365-3156.2004.01233.x 15117306 (Pubitemid 38657287)
13. History, dynamics, and public health importance of malaria parasite resistance. Talisuna AO, Bloland P, D'Alessandro U, Clin Microbiol Rev 2004 17 235 254 10.1128/CMR.17.1.235-254.2004 14726463 (Pubitemid 38120936)
14. Anti-malarial drugs and the prevention of malaria in the population of malaria endemic areas. Greenwood B, Malar J 2010 9 Suppl 3 2 10.1186/1475-2875-9-S3-S2 21144082
15. Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam. Kachur SP, Black C, Abdulla S, Goodman C, Malar J 2006 5 25 10.1186/1475-2875-5-25 16569252
16. Mobile phones and economic development. Aker JC, Mbiti IM, J Economic Perspectives 2010 24 207 232
17. World Health Organization, Partnership for malaria control: engaging the formal and informal private sectors Geneva, World Health Organization/TDR 2006
18. Improving the quality of private sector delivery of public health services: challenges and strategies. Brugha R, Zwi A, Health Policy Plan 1998 13 107 120 10.1093/heapol/13.2.107 10180399 (Pubitemid 28274233)